Navigation Links
Lung Cancer Study Reveals Similar Outcomes for African-American and Caucasian Patients Treated With Alimta®
Date:9/20/2011

.  The unadjusted DCR, or raw data, was 45.8 percent (27 of 59 patients) for the African American study arm and 43.4 percent (116 of 267 patients) for the Caucasian arm.  The odds ratio, a measure of whether a response is more likely in one population than another, indicated the proportions were similar.  This was true on the raw data, as well as after adjustment for relevant factors such as age, gender, smoking status and income.

Median survival for African American patients in the study was 6.9 months (95% CI: 4.5, 8.9) compared with 6.7 months (95% CI: 5.7, 7.9) for Caucasian patients.  In addition, African American patients achieved 3.0 months (95% CI: 2.3, 4.7) of median progression-free survival compared with 2.7 months (95% CI: 2.4, 3.4) for Caucasian patients.  The results indicate that the DCR was non-inferior for African American compared to Caucasian NSCLC patients receiving ALIMTA in this study.

"Traditionally, the vast majority of lung cancer studies have involved Caucasians, so physicians had no way of knowing whether the same results would hold true for other ethnic groups, such as African Americans," said Coleman Obasaju, M.D., Ph.D., senior medical director at Lilly Oncology.  "These kinds of studies help us begin to close this gap and improve health outcomes for all ethnicities."

As part of Lilly's goal to improve health outcomes for individual patients, the company is increasing enrollment of diverse populations in clinical trials and making it easier for patients in minority communities to participate.  Lilly's clinical trial strategy includes forming partnerships with other organizations committed to the same goal, and making efforts to educate and encourage physicians and patients to understand the importance of diverse representation in clinical trials.

About Non-Small Cell Lung Cancer (NSCLC)

Globally, lung cancer is the most common form of cancer and the biggest kil
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Fibich, Leebron, Copeland, Briggs & Josephson is pleased to ... to resolve lawsuits involving individuals who were allegedly harmed ... by Takeda Pharmaceuticals - has been associated with thousands ... firm,s attorneys were instrumental in the coordination and negotiation ... - Founding Partner of Fibich, Leebron, Copeland, Briggs & ...
(Date:5/6/2015)... May 06, 2015 Research and Markets ( ... based Ablation Devices - Global Strategic Business Report" report ... analytics for the US, Canada , ... Asia-Pacific , and Rest of World. Annual estimates ... Also, a seven-year historic analysis is provided for these markets. ...
(Date:5/6/2015)... 6, 2015 3D Communications ... process for helping pharmaceutical companies communicate the value ... The newly expanded 3D Market ... beyond helping companies develop and deliver their "Value ... and engage critical stakeholders earlier in the "innovation-to-market" ...
Breaking Medicine Technology:Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 33D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 23D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 3
... at 24 Months, SAN DIEGO, Dec. 12 ... a Phase 1 clinical trial of CERE-120 in ... therapy to,deliver the neural growth factor neurturin to ... brains of Parkinson,s disease,patients. Long-term follow up assessments ...
... WASHINGTON, Dec. 12 According to data,released by the ... be more likely to consider taking an,over-the-counter (OTC) statin ... use an OTC had decreased since 2004. The findings ... of a joint meeting of two Food and,Drug Administration ...
Cached Medicine Technology:Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 2Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 3Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 4Survey Finds At-Risk Consumers Interested in OTC Statin 2Survey Finds At-Risk Consumers Interested in OTC Statin 3Survey Finds At-Risk Consumers Interested in OTC Statin 4
(Date:5/6/2015)... May 06, 2015 Inversion Studios, ... in yoga and Pilates classes, provides personalized individual ... products, starting with its new Pilates Ring magic ... of becoming leaner, stronger, more centered and graceful, ... a fresh venue to healthy fitness through yoga ...
(Date:5/6/2015)... Wolters Kluwer , a leading ... announced today that in a survey of nearly 16,000 ... the clinical decision support resource improves the quality of ... UpToDate users in more than 170 countries worldwide viewed ... average. In Germany alone, 95% of all university hospitals ...
(Date:5/6/2015)... Beverly Hills, California (PRWEB) May 06, 2015 ... honor of presenting at the 8th Milano Masterclass. As ... the world’s most elite plastic surgeons. Dr. Batniji was ... Academy of Facial Plastic and Reconstructive Surgery, Dr. Pietro Palma. ... year in Milan, Italy. The conference hosts a diverse, ...
(Date:5/6/2015)... May 06, 2015 The Alliance ... the regenerative medicine and advanced therapies community, today ... report, offering an in-depth look at sector trends ... 2015. , The report is available online ... key data points, available here . , ...
(Date:5/6/2015)... Angeles, California (PRWEB) May 06, 2015 ... secured its first round of VC funding and launched ... , The enterprise class embeddable software enables applications to ... data as it moves between systems and locations. Available ... HyperTransfer technology moves files at line speed, independent of ...
Breaking Medicine News(10 mins):Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:California Surgeon Speaks at International Rhinoplasty Conference 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 3Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 2Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 3Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 4
... Fenwal, Inc. today announced,a new partnership with ... data capture and reporting system for Fenwal,s automated ... centers,to export data from Fenwal,s automated blood collection ... standard and customized,reports analyzing critical donor and procedural ...
... 20 EmPower Research, LLC, a pioneer in,the ... its,first-ever study on the Indian Contract Research Organization ... Contract Research Industry, (CRO-nicles),captures the industry,s current position, ... top line industry executives first hand. India ...
... 19 AMICAS, Inc. (Nasdaq: AMCS ),a leader in radiology ... the company,s financial results,for the second quarter ended September 30, 2007, ... http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ), WHEN: ... -- Call begins promptly at 8:30 ...
... Sniffles ,n Sneezes 4 Kids and C-Plus Cold Tablets are specially formulated ... ... With the Food and Drug,Administration (FDA) evaluating the safety and efficacy ... at,a loss for how to treat the symptoms of their children,s cold ...
... NEW YORK, Oct. 19 A new survey ... a third of Hispanic parents are,unaware of available ... aware of where to seek help for ADHD ... treatment including,social stigmas and health system obstacles. ...
... Oct. 19 LeMaitre Vascular,Inc. (Nasdaq: LMAT ... implants for the treatment of peripheral vascular disease, ... Healthcare Conference on,Tuesday, November 6, 2007, in New ... W. LeMaitre, Chairman and Chief Executive Officer, and ...
Cached Medicine News:Health News:Fenwal Signs Development, Distribution and Licensing Agreement With Data Innovations, Inc. 2Health News:EmPower Research Launches Indian CRO Industry Report 2Health News:AMICAS Schedules Third Quarter Earnings Call 2Health News:Hyland's Homeopathic Medicine Offers Parents Safe, All-Natural Option to Alleviate the Symptoms of Colds 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: